Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
CPSE:NOVO B
Novo Nordisk A/S
|
917.10 | -1,79% | 18,59% | 4.053.901,21 | 1,03% | 18,5% |
|
NYSE:JNJ
Johnson & Johnson
|
152.67 | 0% | 0% | 364.323,09 | 3,28% | 2,71% |
|
NYSE:MRK
Merck
|
131.73 | -8,25% | 5,21% | 325.870,86 | 2,39% | -19,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.72 | 17,57% | 40,04% | 189.841,78 | 2,01% | 15,98% |
|
SWX:NOVN
Novartis
|
93.30 | 8,01% | 21,37% | 190.757,59 | 3,53% | 4,67% |
|
NYSE:ABT
Abbott Laboratories
|
104.59 | 2,51% | 15,26% | 180.939,31 | 2,12% | 9,04% |
|
NYSE:PFE
Pfizer
|
28.82 | 9,41% | 39,92% | 160.817,91 | 5,92% | -9,31% |
|
ENXTPA:SAN
Sanofi
|
90.56 | 16,05% | 34,5% | 114.488,32 | 4,1% | 8,19% |
|
NasdaqGS:VRTX
Vertex Pharmaceuticals Inc
|
437.49 | 1,69% | 9,74% | 110.599,1 | 0% | 30,14% |
|
LSE:GSK
GSK
|
18.13 | 5,36% | 20,88% | 73.812,48 | 3,2% | 0,79% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.01 | 21,02% | 30,29% | 84.281,97 | 4,55% | 0,15% |
|
TSE:4502
Takeda Pharmaceutical Company
|
4159.00 | 0% | 0% | 6.597.366,84 | 4,66% | 0% |
|
NasdaqGS:BIIB
Biogen
|
235.32 | -13,85% | 1,44% | 33.033,02 | 0% | -10,89% |
|
XTRA:BAYN
Bayer
|
29.33 | 63,87% | 79,86% | 28.706,43 | 0,38% | 1,47% |
|
ENXTBR:UCB
UCB
|
122.55 | -38,25% | -9,7% | 22.817,51 | 1,13% | -2,55% |
|
NYSE:BAX
Baxter International Inc
|
35.43 | 82,83% | 110,41% | 17.957,61 | 3,29% | -3,14% |
|
TSE:4503
Astellas Pharma
|
1525.00 | 0% | 0% | 2.727.132,35 | 4,87% | 0% |
|
OM:SOBI
Swedish Orphan Biovitrum AB (publ)
|
283.40 | -19,96% | 11,4% | 96.386,6 | 0% | -1,05% |
|
SHSE:600161
Beijing Tiantan Biological Products
|
30.43 | 33,91% | 62,95% | 50.093,41 | 0,5% | 14,53% |
|
SZSE:002252
Shanghai RAAS Blood Products
|
7.51 | 0% | 0% | 49.666,85 | 0,41% | 14,87% |
